Deans' stroke musings: Aspirin ‘not worth the risk’ for healthy women

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, November 27, 2011

Aspirin ‘not worth the risk’ for healthy women

I don't know what to say here since nobody seems to know what to do.

http://www.indianexpress.com/news/aspirin-not-worth-the-risk-for-healthy-women/881097/

Aspirin is not a good investment for healthy women who want to prevent heart attacks or stroke, Dutch researchers say.

They said 50 women would need to take the medication for 10 years for just one to be helped - assuming they are all at high risk to begin with.

“There are very few women who actually benefit,” the Daily Mail quoted Dr Jannick Dorresteijn of University Medical Center Utrecht in The Netherlands, as saying.

“If you don’t want to treat 49 patients for nothing to benefit one, you shouldn’t treat anyone with aspirin.”

The new study adds to a long-standing controversy over aspirin, one of the world’s most widely used drugs. Common side-effects include irritation of the stomach or bowel, heart burn and nausea.

Doctors agree it’s worth taking for people who’ve already had a heart attack or a stroke, but they are less certain when it comes to so-called primary prevention.